New apps and software may bring convenience to our daily lives, but their reach also extends to areas like drug discovery research.
Bacteria-Driven Drug Delivery Carriers: A Paradigm Shift
Bacteria-driven microswimmers can release the therapeutic drug specifically at the site of disease by attaching to a certain type of eukaryotic cell.
Using PyMOL as a Platform for Computational Drug Design
A recent review discusses various molecular modeling modules in PyMOL, covering those for visualization and analysis enhancement, protein-ligand modeling, molecular simulations and drug screening.
Quantum Chemical Drug Research
Dr. Irina Kufareva and her colleagues from UC San Diego have investigated quantum chemical approaches to computational drug research.
The challenges in moving beyond animal models in research
Animal testing remains a principle screening tool in the drug discovery pipeline, but are they reliable and could there be alternatives to replace them?
Human-on-a-chip provides an accurate model for the immune system
A new in vitro model of the body’s immune system better predicts its response to new therapeutics, potentially lowering the high costs and low success rates of drug discovery.
PROTACs: Eliminating Disease-Causing Proteins
PROTACs (proteolysis-targeting chimeric molecules): A review and discussion of the technique and its application to therapies and drug discovery.
Scaffold-free tissue engineering to create a human neural tissue construct
This new tissue engineering approach may be useful to establish a technology for regenerative medicine and drug discovery using the patient’s own neurons.
AI and robotics join forces to revamp how medications are made
Scientists are speeding up drug formulation to breath new life into old medications and reduce risk of clinical trial failure.
Researchers uncover a fundamental driver behind osteoarthritis
The first link between biomolecule concentration in our cartilage and the progression of osteoarthritis opens new routes for treatment.